Source: BioE Corporation
Posted: November 1, 2006
Summary:
BioE®, Inc., a biomedical company providing human umbilical cord blood stem cells as enabling, high-quality cellular tools for drug discovery and therapeutic research, announced a report published in the latest issue (Vol. 8, Issue 5) of the journal Cytotherapy confirms its Multi-Lineage Progenitor Cell™ (MLPC™) is the first human cord blood stem cell to differentiate into a type II alveolar lung cell, responsible for secreting surfactant, a material that helps stabilize the lung’s air sacs during respiration.
Commentary: Maybe this advance will lead to new stem cell treatments for lung and respiratory diseases.
No comments:
Post a Comment